UBS Group’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.07M | Buy |
2,646,556
+1,010
| +0% | +$1.17K | ﹤0.01% | 3466 |
|
|
2025
Q1 | $3.57M | Buy |
2,645,546
+2,017,265
| +321% | +$2.72M | ﹤0.01% | 3243 |
|
|
2024
Q4 | $8.27M | Buy |
628,281
+397,973
| +173% | +$5.24M | ﹤0.01% | 2528 |
|
|
2024
Q3 | $2.58M | Buy |
230,308
+78,106
| +51% | +$876K | ﹤0.01% | 2834 |
|
|
2024
Q2 | $1.64M | Sell |
152,202
-212,862
| -58% | -$2.29M | ﹤0.01% | 3020 |
|
|
2024
Q1 | $5.44M | Buy |
365,064
+22,891
| +7% | +$341K | ﹤0.01% | 2114 |
|
|
2023
Q4 | $6.2M | Buy |
342,173
+71,369
| +26% | +$1.29M | ﹤0.01% | 1814 |
|
|
2023
Q3 | $4.7M | Buy |
270,804
+267,780
| +8,855% | +$4.64M | ﹤0.01% | 1904 |
|
|
2023
Q2 | $54.8K | Sell |
3,024
-11,536
| -79% | -$209K | ﹤0.01% | 5358 |
|
|
2023
Q1 | $387K | Buy |
14,560
+9,165
| +170% | +$244K | ﹤0.01% | 3883 |
|
|
2022
Q4 | $104K | Sell |
5,395
-1,205
| -18% | -$23.3K | ﹤0.01% | 4939 |
|
|
2022
Q3 | $138K | Buy |
6,600
+3,063
| +87% | +$64K | ﹤0.01% | 4388 |
|
|
2022
Q2 | $28K | Buy |
3,537
+550
| +18% | +$4.35K | ﹤0.01% | 5446 |
|
|
2022
Q1 | $21K | Sell |
2,987
-7,334
| -71% | -$51.6K | ﹤0.01% | 6356 |
|
|
2021
Q4 | $140K | Buy |
10,321
+8,391
| +435% | +$114K | ﹤0.01% | 4928 |
|
|
2021
Q3 | $32K | Buy |
1,930
+533
| +38% | +$8.84K | ﹤0.01% | 5575 |
|
|
2021
Q2 | $41K | Buy |
1,397
+501
| +56% | +$14.7K | ﹤0.01% | 5543 |
|
|
2021
Q1 | $35K | Sell |
896
-483
| -35% | -$18.9K | ﹤0.01% | 5870 |
|
|
2020
Q4 | $32K | Sell |
1,379
-1,131
| -45% | -$26.2K | ﹤0.01% | 5575 |
|
|
2020
Q3 | $57K | Buy |
+2,510
| New | +$57K | ﹤0.01% | 4703 |
|